Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease
- 1 July 1997
- journal article
- Published by Elsevier in Brain Research
- Vol. 763 (2) , 145-158
- https://doi.org/10.1016/s0006-8993(97)00384-3
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Regional differences in gene expression for calcium activated neutral proteases (calpains) and their endogenous inhibitor calpastatin in mouse brain and spinal cordJournal of Neurobiology, 1996
- Purification and Properties of High Molecular Weight Calpastatin from Bovine BrainJournal of Neurochemistry, 1995
- Immunological and conformational characterization of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's diseaseBiochemical and Biophysical Research Communications, 1992
- Immunoassay and Activity of Calcium‐Activated Neutral Proteinase (mCANP): Distribution in Soluble and Membrane‐Associated Fractions in Human and Mouse BrainJournal of Neurochemistry, 1992
- Demonstration of neurofibrillary tangles in parvalbumin-immunoreactive interneurones in the cerebral cortex of Alzheimer-type dementia brainNeuroscience Letters, 1991
- Comparison of the autolyzed and unautolyzed forms of μ- and m-calpain from bovine skeletal muscleBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1991
- A modified form of microtubule-associated tau protein is the main component of paired helical filamentsBiochemical and Biophysical Research Communications, 1988
- Are alzheimer neurofibrillary tangles insoluble polymers?Life Sciences, 1986
- A Calcium‐Activated Protease which Preferentially Degrades the 160‐kDa Component of the Neurofilament TripletEuropean Journal of Biochemistry, 1983
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970